Brief: Dimerix And FUSO Enter Into Exclusive Development And License Agreement To Commercialise DMX-200 In Japan
07/01/2025 24:39
Jan 7 (Reuters) - Dimerix Ltd DXB.AX :
* DIMERIX AND FUSO ENTER INTO EXCLUSIVE DEVELOPMENT AND
LICENSE
AGREEMENT TO COMMERCIALISE DMX-200 IN JAPAN
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions